跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ACETAMINOPHEN INJECTION
Authorized
STANDARD
ACETAMINOPHEN INJECTION
B. Braun Melsungen AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1d70dc347eb926cd
Company
B. Braun Melsungen AG
Type
Standard
Approval Details
Approval Id
1d70dc347eb926cd
Drug Approval Canada Name
ACETAMINOPHEN INJECTION
Product Name
ACETAMINOPHEN INJECTION
Status
Marketed
Status Date
2023-12-15
Original Market Date
2023-12-15
Din
02535742
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:08.92
Atc Original
N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name
n 02 be 01
Aig Number
0102009015
Company Name
B. Braun Melsungen AG
Company Address
Carl-Braun-Str. 1, Melsungen, Hessen, Germany, 34212
Company Detail Path
/organization/b-braun-melsungen-ag
Company Information
Pharmaceutical Company Name
B. Braun Melsungen AG
Country Name
Germany
Province Name
hessen,country_de
City Name
melsungen,hessen,country_de
Address
Carl-Braun-Str. 1
Website
https://www.bbraun.com/en.html
Active Ingredients
ACETAMINOPHEN
500 MG / 50 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1d70dc347eb926cd
Type
Standard
Back to Health Canada Approvals
ACETAMINOPHEN INJECTION - Health Canada Drug Approval Details